Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
- 24 August 2016
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (36) , E5328-E5336
Abstract
Significance: There are no effective therapies currently available for advanced pancreatic cancer. We show that there are two populations of cancer cells within a pancreatic tumor that require targeting by different metabolic inhibitors for effective tumor control. Rapidly dividing cells use glutamine, and can be effectively killed by administration of a nanoparticle containing an inhibitor of glutamine metabolism. Hypoxic cells, which are slowly dividing cells, metabolize glucose and can be targeted by metformin, a drug used for the treatment of diabetes. Clinical trials are needed to determine whether combination therapy, with drugs that effectively block the metabolism of glutamine and glucose, improves the survival of patients with pancreatic cancer.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (R01-CA193895)
- HHS | NIH | National Institute on Drug Abuse (R03-DA032470)
- HHS | NIH | National Cancer Institute (R21-CA169757)
- HHS | NIH | National Institute of Mental Health (P30-MH075673)
- HHS | NIH | National Center for Advancing Translational Sciences (UL1-TR001079)
This publication has 60 references indexed in Scilit:
- Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinomaProceedings of the National Academy of Sciences, 2013
- Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolismProceedings of the National Academy of Sciences, 2012
- Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolismProceedings of the National Academy of Sciences, 2012
- Five Primary Human Pancreatic Adenocarcinoma Cell Lines Established by the Outgrowth MethodJournal of Surgical Research, 2012
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B CellsCell Metabolism, 2012
- NMR-based stable isotope resolved metabolomics in systems biochemistryJournal of Biomolecular NMR, 2011
- Stable isotope resolved metabolomics of lung cancer in a SCID mouse modelMetabolomics, 2010
- Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progressionProceedings of the National Academy of Sciences, 2010
- Isotopomer analysis of lipid biosynthesis by high resolution mass spectrometry and NMRAnalytica Chimica Acta, 2009
- Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addictionProceedings of the National Academy of Sciences, 2008